Literature DB >> 8270231

Peritoneal metastases in pancreatic carcinoma.

C F del Castillo1, L Warshaw.   

Abstract

Peritoneal metastases are present in about 50% of patients with pancreatic cancer at the time of death, and are the second most common site of involvement, following the liver. The small size of peritoneal metastases precludes their identification by CT scan, and thus they have to be identified by direct visualization, either at laparotomy or through laparoscopy. Adding laparoscopy to the staging protocol permits pre-operative identification of patients who will not benefit from surgery. Malignant cells are also found within the peritoneal cavity in 20 to 30% of patients with pancreatic cancer who otherwise have no peritoneal or liver metastases. Their presence, documented by peritoneal washings during laparoscopy or at the time of surgery, seems to be associated with an adverse prognosis.

Entities:  

Mesh:

Year:  1993        PMID: 8270231

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  17 in total

Review 1.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

2.  The role of laparoscopy in the preoperative staging of pancreatic carcinoma.

Authors:  B Rumstadt; M Schwab; K Schuster; E Hagmüller; M Trede
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

Review 3.  Results of adjuvant therapy in resected pancreatic cancer.

Authors:  A Andrén-Sandberg; P L Bäckman; R Andersson
Journal:  Int J Pancreatol       Date:  1997-02

4.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

5.  PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer.

Authors:  Richard Kim; Gopi Prithviraj; Nishi Kothari; Greg Springett; Mokenge Malafa; Pamela Hodul; Jongphil Kim; Binglin Yue; Brian Morse; Amit Mahipal
Journal:  Clin Nucl Med       Date:  2015-11       Impact factor: 7.794

Review 6.  Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.

Authors:  Jessie L-S Au; Ze Lu; M Guillaume Wientjes
Journal:  AAPS J       Date:  2015-06-19       Impact factor: 4.009

Review 7.  Intraperitoneal therapy for peritoneal cancer.

Authors:  Ze Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  Future Oncol       Date:  2010-10       Impact factor: 3.404

8.  Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis.

Authors:  Hiroaki Aoki; Masayo Aoki; Eriko Katsuta; Rajesh Ramanathan; Michael O Idowu; Sarah Spiegel; Kazuaki Takabe
Journal:  J Surg Res       Date:  2016-07-09       Impact factor: 2.192

9.  Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.

Authors:  Jie Wang; Ze Lu; Bertrand Z Yeung; M Guillaume Wientjes; David J Cole; Jessie L-S Au
Journal:  J Control Release       Date:  2014-01-23       Impact factor: 9.776

10.  Laparoscopic peritoneal lavage cytology and immunocytology in pancreatic and periampullary carcinoma.

Authors:  M J Midwinter; A Watson; V Wadehra; R M Charnley
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.